ABI
LDRH

Adamant Biomedical Investments’s LDR HOLDINGS CORP COM STK LDRH Stock Holding History

Adamant Biomedical Investments’s Portfolio LDRH Stock Details LDRH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-33,000
Closed -$1.03M – 107
2014
Q3 		$1.03M Buy
+33,000
New +$855K 0.26% 77

Other funds holding LDRH

THP
Telegraph Hill Partners San Francisco, California $159M AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Adamant Biomedical Investments's LDRH Position: Q4 2014 in Review

Adamant Biomedical Investments sold out of LDR HOLDINGS CORP COM STK (LDRH) in Q4 2014, closing a stake of 33,000 shares — an estimated $1.03M sold.

Adamant Biomedical Investments first reported a position in LDRH in Q3 2014 and held it in 1 quarter. The position peaked at $1.03M in Q3 2014. 125 funds tracked by Wall St. Rank hold LDRH as of Q4 2014.

  • Adamant Biomedical Investments reported no remaining LDR HOLDINGS CORP COM STK position as of Q4 2014 after selling out during the quarter.
  • Adamant Biomedical Investments sold 33,000 LDR HOLDINGS CORP COM STK shares in Q4 2014, an estimated $1.03M.
  • Adamant Biomedical Investments first reported a position in LDR HOLDINGS CORP COM STK in Q3 2014 and held it in 1 quarter.
  • Adamant Biomedical Investments's LDR HOLDINGS CORP COM STK position peaked at $1.03M in Q3 2014.
  • 125 funds tracked by Wall St. Rank held LDR HOLDINGS CORP COM STK as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.